Report - Oppenheimer & Co.€¦ · AV-101 may achieve therapeutic benefit, including Parkinson’s disease levodopa -induced dyskinesia (PD LID), epilepsy and Huntington’s disease. Clinical

Please pass captcha verification before submit form